Royalty Pharma (NASDAQ:RPRX) just reported results for the first quarter of 2024.
- Royalty Pharma reported earnings per share of 98 cents. This was below the analyst estimate for EPS of 99 cents.
- The company reported revenue of $568.00 million.
- This was 14.36% worse than the analyst estimate for revenue of $663.22 million.